Dr. Lal Pathlabs Limited — Capital/Financing Update 2020

Apr 16, 2020

==> picture [596 x 88] intentionally omitted <==

April 16, 2020

National Stock Exchange of India Limited Exchange Plaza, Plot No. C/1, G Block, Bandra Kurla Complex Bandra (E) Mumbai – 400 051.

BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers Dalal Street Mumbai- 400001

Dear Sir/Madam,

Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure - Requirements) Regulations, 2015 Credit Rating

Please take note that CRISIL vide its letter dated April 15, 2020, has assigned the following Credit Rating for the debt instruments/facilities of the Company:

Total Bank Loan Facilities Rated	INR 60 Crore
Long-Term Rating	CRISIL AA-/Stable
Short-Term Rating	CRISIL A1+

CRISIL has also confirmed that such letter will remain valid till March 31, 2021

We request you to please take the same on record.

Thanking You,

Yours Faithfully,

For Dr. Lal PathLabs Limited

==> picture [81 x 40] intentionally omitted <==

==> picture [57 x 52] intentionally omitted <==

Rajat Kalra

Company Secretary and Legal Head

==> picture [596 x 88] intentionally omitted <==